Epirium Bio inks $85 mln Series A
San Diego-based Epirium Bio Inc, a clinical-stage biopharmaceutical company, has raised $85 million in Series A financing.
San Diego-based Epirium Bio Inc, a clinical-stage biopharmaceutical company, has raised $85 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination